Untitled Document

Management Page Banner

Management

Pantelis Stanitsas: Neuraxon, Ltd., President & CEO, Greece
(an MDCorp Company) pantelis.stanitsas@neuraxon.gr

MDCorp’s management team has over twenty years of experience in the Europe clinical investment markets to include significant advisory board access to Asian markets. With a range of expertise and experience, MDCorp is prepared to educate, advocate, and promote its technology throughout both its proven markets and new markets with increased capital access and where end client demand for our products create differentiated service opportunities and related net margin.


Anastasios Tantaroudas: Neuraxon, Chief Financial Officer
(an MDCorp Company) anastasios.tantaroudas@neuraxon.gr

MDCorp’s management team has over twenty years of experience in the Europe clinical investment markets to include significant advisory board access to Asian markets. With a range of expertise and experience, MDCorp is prepared to educate, advocate, and promote its technology throughout both its proven markets and new markets with increased capital access and where end client demand for our products create differentiated service opportunities and related net margin.


Stefanos Vallas: Neuraxon, Commercial Director
(an MDCorp Company) stefanos.vallas@neuraxon.gr

MDCorp’s management team has over twenty years of experience in the Europe clinical investment markets to include significant advisory board access to Asian markets. With a range of expertise and experience, MDCorp is prepared to educate, advocate, and promote its technology throughout both its proven markets and new markets with increased capital access and where end client demand for our products create differentiated service opportunities and related net margin.


Dr. Thomas Dimitracopoulos : Neuraxon, Clinical Director
(an MDCorp Company) thomas.dimitracopoulos@neuraxon.gr

Neurology specialization (residency) lasted 5 years, Sparta Hospital, six months of psychiatry service at Attica Psychiatric Hospital and 45 months of Neurology service performed in the General Hospital of Elefsina Thriasio. The residency includes demonstrated competency in clinical neurology and neuroscience related domains (neurophysiology, neurosurgery and neuroradiology).

Additionally, Dr. Dimiracopoulos attended the Faculty of Medicine of the University of Medicine and Pharmacy Victor Babes Timisoara, Romania.

Over a period of several years he was trained, worked and served in the capacity of intraoperative neurophysiological monitoring training. Dr. Dimiracopoulos collaborated with enhanced specialties, such as neurosurgery, orthopedics, ENT, general surgery, during surgery.


Ilias Apatsidis : Neuraxon, Business Development Director
(an MDCorp Company) ilias.apatsidis@neuraxon.gr

Neuraxon Area Manager, formerly with Johnson & Johnson Hellas as Tendering Manager Responsible to manage, lead and develop tendering department employees. Managed to adopt digital offering
procedure and create proper conditions for zero mistakes in tender participations and retain Market share in major product categories (Hydrocephalus & ICU) and increase volume and value in
neurosurgical disposables and Drug Delivery. Established Neurovascular business with market share more than 25%. and as Sales Specialist Codman responsible to provide product expertise to customers and meet sales goals in South Region where he achieved double digit, annual average, growth on the assigned territory. Former technical training and work with Specialist Carl Zeiss Surgical Microscopes responsible to meet sales goals in Greek Market and provide training/technical expertise in product users. Growth, through retention of high value / low volume market and ‘’creation’’ of low value / high volume market (especially dental market).